Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

COVID-19 can cause temporary hair loss.

Covid-19 can cause hair loss due to immune and psychological factors.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

COVID-19 protective measures led to skin irritation, hair loss, and brittle nails; using skin-friendly products and a healthy diet is recommended.

A man had nail and hair changes months after severe Covid-19, showing long-term effects.

The pandemic stress may have increased alopecia cases in Bangladesh.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

COVID-19 vaccines do not increase the risk of alopecia areata.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

COVID-19 may harm male fertility and damage the reproductive system.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

The treatment might help COVID-19 related hair loss, but more research is needed.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.